Juan Diego Ciro Quintero

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

C. Sampaio, I. Roberts, I. Rätsep, 2009, Trials.

TRIAL : a randomised , placebo controlled trial of a Bradykinin B 2 receptor antagonist ( Anatibant ) in patients with traumatic brain injury

C. Sampaio, I. Roberts, I. Rätsep, 2018 .

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

C. Sampaio, I. Roberts, I. Rätsep, 2009, Trials.